<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3379">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01394159</url>
  </required_header>
  <id_info>
    <org_study_id>F110506010</org_study_id>
    <nct_id>NCT01394159</nct_id>
  </id_info>
  <brief_title>22G FNA Needle vs. 22G ProCore Needle</brief_title>
  <official_title>Randomized Trial Comparing the 22-gauge Aspiration and 22-gauge Biopsy Needles for EUS-guided Sampling of Solid Pancreatic Mass Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shyam Varadarajulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Florida Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this research study is to identify the best needle for performing biopsy during
      EUS procedures. There are two types of needles for performing biopsy: A FNA needle that
      provides a small sample of tissue for analysis and a ProCore needle that provides larger
      amount of tissue. It is not clear at this point which of the two needles is superior for
      performing biopsy. This study will attempt to identify the better needle by assessing the
      performance of both needles in a randomized fashion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this randomized trial, the 22G fine needle aspiration needle was compared with the newly
      developed 22G ProCore needle for sampling pancreatic mass lesions during endoscopic
      ultrasound. Patients were randomized into the two needle groups and then various outcomes
      were compared between the two needle types, including the number of passes needed to
      establish a diagnosis, the ability to procure enough tissue sample to be able to make a
      diagnosis, the rates of needle failure and complication rates.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Compare the Median Number of Passes Required to Establish a Diagnosis</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnosis Achieved With the Needle</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Technical Failure</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Malfunction of the needle during endoscopic ultrasound-guided sampling of the pancreatic mass lesion before a diagnosis is achieved</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Pancreatic Neoplasm</condition>
  <arm_group>
    <arm_group_label>22G ProCore needle</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use the 22G ProCore needle for sampling pancreatic mass lesions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>22G standard FNA needle</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Use the 22G standard find needle aspiration needle (FNA) for sampling pancreatic mass lesions</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>22G Procore biopsy needle</intervention_name>
    <description>Acquire tissue with the 22G Procore biopsy needle</description>
    <arm_group_label>22G ProCore needle</arm_group_label>
    <other_name>Acquire tissue with ProCore needle</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>22G FNA needle</intervention_name>
    <description>Acquire tissue with the 22G FNA needle</description>
    <arm_group_label>22G standard FNA needle</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -All patients with solid pancreatic mass lesions

        Exclusion Criteria:

          -  Coaguloapthy,

          -  minors,

          -  prgenant patients
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shyam Varadarajulu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Alabama at Birmingham</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama at Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <lastchanged_date>March 30, 2015</lastchanged_date>
  <firstreceived_date>July 12, 2011</firstreceived_date>
  <firstreceived_results_date>March 18, 2015</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Florida Hospital</investigator_affiliation>
    <investigator_full_name>Shyam Varadarajulu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>passes required to establish diagnosis</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pancreatic Neoplasms</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>22G ProCore Biopsy</title>
          <description>Acquire biopsy with procore needle
Procore Biopsy: Acquire tissue with procore biopsy needle</description>
        </group>
        <group group_id="P2">
          <title>22G FNA Needle</title>
          <description>Acquire tissue with 22 gauge fine needle aspiration needle</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ProCore Biopsy</title>
          <description>Acquire biopsy with procore needle
Procore Biopsy: Acquire tissue with procore biopsy needle</description>
        </group>
        <group group_id="B2">
          <title>FNA Needle</title>
          <description>FNA: Acquire tissue with FNA needle</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="28"/>
                <measurement group_id="B2" value="28"/>
                <measurement group_id="B3" value="56"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="65.0" spread="15.4"/>
                <measurement group_id="B2" value="65.4" spread="11.1"/>
                <measurement group_id="B3" value="65.2" spread="13.3"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="13"/>
                <measurement group_id="B2" value="12"/>
                <measurement group_id="B3" value="25"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="15"/>
                <measurement group_id="B2" value="16"/>
                <measurement group_id="B3" value="31"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>White</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="22"/>
                <measurement group_id="B2" value="21"/>
                <measurement group_id="B3" value="43"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Black</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="6"/>
                <measurement group_id="B2" value="7"/>
                <measurement group_id="B3" value="13"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>United States</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="28"/>
                <measurement group_id="B2" value="28"/>
                <measurement group_id="B3" value="56"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Compare the Median Number of Passes Required to Establish a Diagnosis</title>
        <time_frame>6 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>22G ProCore Biopsy</title>
            <description>Acquire biopsy with procore needle
Procore Biopsy: Acquire tissue with procore biopsy needle</description>
          </group>
          <group group_id="O2">
            <title>22G FNA Needle</title>
            <description>Acquire tissue with 22 gauge fine needle aspiration needle</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="28"/>
                  <measurement group_id="O2" value="28"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Compare the Median Number of Passes Required to Establish a Diagnosis</title>
            <units>No. of passes for diagnosis</units>
            <param>Median</param>
            <dispersion>Inter-Quartile Range</dispersion>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1" lower_limit="1" upper_limit="1"/>
                  <measurement group_id="O2" value="1" lower_limit="1" upper_limit="2.5"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diagnosis Achieved With the Needle</title>
        <time_frame>6 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>22G ProCore Biopsy</title>
            <description>Acquire biopsy with procore needle
Procore Biopsy: Acquire tissue with procore biopsy needle</description>
          </group>
          <group group_id="O2">
            <title>22G FNA Needle</title>
            <description>Acquire tissue with 22 gauge fine needle aspiration needle</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="28"/>
                  <measurement group_id="O2" value="28"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Diagnosis Achieved With the Needle</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="25"/>
                  <measurement group_id="O2" value="28"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Technical Failure</title>
        <description>Malfunction of the needle during endoscopic ultrasound-guided sampling of the pancreatic mass lesion before a diagnosis is achieved</description>
        <time_frame>6 months</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>22G ProCore Biopsy</title>
            <description>Acquire biopsy with procore needle
Procore Biopsy: Acquire tissue with procore biopsy needle</description>
          </group>
          <group group_id="O2">
            <title>22G FNA Needle</title>
            <description>Acquire tissue with 22 gauge fine needle aspiration needle</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="28"/>
                  <measurement group_id="O2" value="28"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Technical Failure</title>
            <description>Malfunction of the needle during endoscopic ultrasound-guided sampling of the pancreatic mass lesion before a diagnosis is achieved</description>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="1"/>
                  <measurement group_id="O2" value="0"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>22G ProCore Biopsy</title>
          <description>Acquire biopsy with procore needle
Procore Biopsy: Acquire tissue with procore biopsy needle</description>
        </group>
        <group group_id="E2">
          <title>22G FNA Needle</title>
          <description>Acquire tissue with 22 gauge fine needle aspiration needle</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>abdominal pain</sub_title>
                <description>This patient was in the FNA group and was managed conservatively</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="28"/>
              </event>
              <event>
                <sub_title>Mild acute pancreatitis</sub_title>
                <description>This patient was managed conservatively</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="28"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Shyam Varadarajulu</name_or_title>
      <organization>Center for Interventional Endoscopy, Florida Hospital</organization>
      <phone>407-303-2570</phone>
      <email>svaradarajulu@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
